Stay updated with breaking news from James bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amgen's new research and development facility in San Francisco. (courtesy photo) Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their ....
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market. ....
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market. ....
Amgen stock falls as analysts debate weight loss prospects (NASDAQ:AMGN) seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.